The Implementation of a Novel Kidney Function Biomarker in Clinical Routine
Even though AKI affects 1 in 3 patients in the intensive care units, there is a significant unmet need generated by late…
Point-of-care Diagnostics in the Emergency Department: Better Patient Management
Near patient diagnostics can greatly improve the time to intervention and the outcomes for the severely sick patients…
Using Proenkephalin as a Novel Biomarker to Estimate GFR
The standard of care to determine kidney function has significant limitations, including late detection of changes in kidney function and the…
Our skilled international team has a breadth of experience in life sciences, disease biology, biotechnology, and clinical in vitro diagnostics and is dedicated to supporting the medical community and…
For higher throughput, IVD tests for SphingoTec’s proprietary biomarkers for critical care and preventive medicine are made available as sphingotest® microtiterplate assays.
SphingoTec is pleased to announce the following appointments to its management team: Deborah Bergmann as Managing Director and Chief Executive Officer (CEO), Dr. Florian Uhle as Managing Director and…
Bioactive Adrenomedullin (bio-ADM), is a dynamic biomarker for the real time assessment of endothelial function. Loss of endothelial function is causing the formation of edema, shock and subsequent…
PenKid Whitepaper
The whitepaper covers practical insights on the AKI diagnostics and highlights the scientific evidence for penKid, a kidney function biomarker.
Click here to download the…
